[(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain (Q44481114)

3 December 2017

[(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain (English)

1 reference

3 December 2017

0 references

10

1 reference

3 December 2017

1

Christer Halldin

1 reference

3 December 2017

11

Lars Farde

1 reference

3 December 2017

Nina Erixon-Lindroth

2

1 reference

3 December 2017

Stefan Pauli

3

1 reference

3 December 2017

Yuan-Hwa Chou

4

1 reference

3 December 2017

Yoshiro Okubo

5

1 reference

3 December 2017

Per Karlsson

6

1 reference

3 December 2017

Camilla Lundkvist

7

1 reference

3 December 2017

Hans Olsson

8

1 reference

3 December 2017

Denis Guilloteau

9

1 reference

3 December 2017

13 June 2003

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

3 December 2017

1 reference

3 December 2017

30

1 reference

3 December 2017

9

1 reference

3 December 2017

1220-1230

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-003-1212-3

3 December 2017

0 references

cites work

Radiosynthesis of [18F] N-3-fluoropropyl-2-beta-carbomethoxy-3-beta-(4-iodophenyl) nortropane and the first human study with positron emission tomography

1 reference

12 December 2020

Improved synthesis of some commonly used PET radioligands by the use of [11C]methyl triflate.

1 reference

12 December 2020

Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imaging.

1 reference

12 December 2020

PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain.

1 reference

12 December 2020

Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT.

1 reference

12 December 2020

Dopamine transporter density in patients with attention deficit hyperactivity disorder.

1 reference

12 December 2020

Regional brain uptake and pharmacokinetics of [123I]N-omega-fluoroalkyl-2 beta-carboxy-3 beta-(4-iodophenyl)nortropane esters in baboons

1 reference

12 December 2020

Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease

1 reference

12 December 2020

Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I.

1 reference

12 December 2020

[123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder

1 reference

12 December 2020

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

1 reference

12 December 2020

[123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain.

1 reference

12 December 2020

[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression

1 reference

12 December 2020

Exploration of the dopamine transporter: in vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-m ethylph enyl)nortropane (PE2I).

1 reference

12 December 2020

[18F] beta-CIT-FP is superior to [11C] beta-CIT-FP for quantitation of the dopamine transporter.

1 reference

12 December 2020

Stereoselective binding of 11C-raclopride in living human brain--a search for extrastriatal central D2-dopamine receptors by PET.

1 reference

12 December 2020

The ECAT EXACT HR: performance of a new high resolution positron scanner.

1 reference

12 December 2020

Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters

1 reference

12 December 2020

[125I] beta-CIT-FE and [125I] beta-CIT-FP are superior to [125I] beta-CIT for dopamine transporter visualization: autoradiographic evaluation in the human brain.

1 reference

12 December 2020

Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT.

1 reference

12 December 2020

Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography

1 reference

12 December 2020

Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis

1 reference

12 December 2020

[11C]beta-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography.

1 reference

12 December 2020

[18F]CFT [(18F)WIN 35,428], a radioligand to study the dopamine transporter with PET: characterization in human subjects.

1 reference

12 December 2020

Head fixation device for reproducible position alignment in transmission CT and positron emission tomography

1 reference

12 December 2020

Synthesis and ligand binding of nortropane derivatives: N-substituted 2beta-carbomethoxy-3beta-(4'-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3',4'-disubstituted phenyl)nortropane. New high-affinity and selective co

1 reference

12 December 2020

PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor.

1 reference

12 December 2020

Three-dimensional visualization and quantification of the benzodiazepine receptor population within a living human brain using PET and MRI

1 reference

12 December 2020

The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action

1 reference

12 December 2020

Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)n ortropane as a selective and potent inhibitor of the neuronal dopamine transporter.

1 reference

12 December 2020

Iodine-123 labelled N-(2-fluoroethyl)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)nortropane for dopamine transporter imaging in the living human brain.

1 reference

12 December 2020

Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [11C]raclopride binding

1 reference

12 December 2020

[11C] beta-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigations.

1 reference

12 December 2020

Striatal dopamine transporter density in major depression

1 reference

12 December 2020

Maprotiline: a review of its pharmacological properties and therapeutic efficacy in mental depressive states

1 reference

12 December 2020

In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428.

1 reference

12 December 2020

N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters.

1 reference

12 December 2020

Brain radioligands--state of the art and new trends

1 reference

12 December 2020

Altropane, a SPECT or PET imaging probe for dopamine neurons: II. Distribution to dopamine-rich regions of primate brain

1 reference

12 December 2020

PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride.

1 reference

12 December 2020

1 reference

12 December 2020

Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity

1 reference

12 December 2020

10.1007/S00259-003-1212-3

Identifiers

DOI

1 reference

3 December 2017

1 reference